Note: Ingredients listed on restricted chemical lists
EC/CAS
212-485-8/822-06-0
Name of the chemical
Hexamethylene diisocyanate
Concentration
≥0.5%
General Information
Version
1.01
Revision date
2025-11-25
Product name
PUR 4545-99
1.2.1 Relevant identified uses
Hardener
Icons in SDS
Company Information
company name
Teknos Group Oy
e-mail address of the competent person responsible for the Safety Data Sheet
Prod-safe@teknos.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H332, H335, H412
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Warning
Hazard statements
H317 - May cause an allergic skin reaction. H332 - Harmful if inhaled. H335 - May cause respiratory irritation. H412 - Harmful to aquatic life with long lasting effects.
Prevention
P280 - Wear protective gloves. P273 - Avoid release to the environment. P261 - Avoid breathing vapour.
Response
P304 + P312 - IF INHALED: Call a POISON CENTER or doctor if you feel unwell.
Storage
P403 + P233 - Store in a well-ventilated place. Keep container tightly closed.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national and international regulations.
Contains
Aliphatic polyisocyanate and Hexamethylene-di-isocyanate
Supplemental label elements
Contains isocyanates. May produce an allergic reaction.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Acute Tox. 4, H332 Skin Sens. 1, H317 STOT SE 3, H335 Aquatic Chronic 3, H412 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
